(Q45077882)

9 December 2017

title

The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea (English)

1 reference

9 December 2017

Nayoung Kim

1 reference

9 December 2017

Hyun Chae Jung

1 reference

9 December 2017

Jung Mook Kang

1 reference

9 December 2017

Gheeyoung Choe

1 reference

9 December 2017

Ji Youn Yoo

1 reference

9 December 2017

Young Soo Park

1 reference

9 December 2017

Dong Ho Lee

1 reference

9 December 2017

Hyun Young Kim

1 reference

9 December 2017

Hye Seung Lee

1 reference

9 December 2017

Joo Sung Kim

1 reference

9 December 2017

In Sung Song

1 reference

9 December 2017

language of work or name

1 reference

1 April 2008

1 reference

9 December 2017

1 reference

9 December 2017

1 reference

9 December 2017

1 reference

9 December 2017

page(s)

146-156

1 reference

The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects.

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Gastric cancer screening using the serum pepsinogen test method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Using serum pepsinogens wisely in a clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Serum pepsinogen and gastric cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Gastrin and cancer: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Detection rate of Helicobacter pylori against a background of atrophic gastritis and/or intestinal metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pylori in dyspeptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

The relation of pepsinogen group II (PGII) expression to intestinal metaplasia and gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Review article: molecular basis of gastric carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylori out of the gastric mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Seroprevalence of Helicobacter pylori in South Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2008.00592.X

10.1111/J.1523-5378.2008.00592.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference